| Literature DB >> 31488227 |
Farooq Naeem1, Tariq Munshi2, David Gratzer3, David Rodie4, Muhammad Irfan5, Sanjay Rao6, Nusrat Husain7, Saeed Farooq8, Marcos Sanches9, Muhammad Ayub10, Tania Lecomte11.
Abstract
BACKGROUND: The waiting room in psychiatric services can provide an ideal setting for offering evidence-based psychological interventions that can be delivered through electronic media. Currently, there is no intervention available that have been developed or tested in mental health. AIMS: This proof-of-concept study aimed to evaluate a pilot design of RESOLVE (Relaxation Exercise, SOLving problem and cognitiVe Errors) to test the procedure and obtain outcome data to inform future, definitive trials (trial registration at Clinicaltrials.gov NCT02536924, REB Number: PSIY-477-15).Entities:
Keywords: Waiting room; breathing; cognitive errrors; problem solving; video intervention
Year: 2019 PMID: 31488227 PMCID: PMC6737517 DOI: 10.1192/bjo.2019.59
Source DB: PubMed Journal: BJPsych Open ISSN: 2056-4724
Fig. 1Consort flow diagram of the trial.
Differences in demographic variables and psychopathology between the intervention and the control groups at baseline
| Intervention ( | Control (TAU) ( | ||
|---|---|---|---|
| Age, mean (s.d.) | 28.8 (10.7) | 31.2 (9.4) | <0.081 |
| Past history of psychiatric admissions, mean (s.d.) | 2.60 (2.21) | 2.30 (3.1) | <0.461 |
| Gender, | |||
| Men | 9 (45) | 10 (50) | <1.000 |
| Women | 11 (55) | 10 (50) | |
| Ethnicity, | |||
| White | 16 (80) | 16 (80) | <1.000 |
| Black and minority ethnic | 4 (20) | 4 (20) | |
| Marital status, | |||
| Married or in a partnership | 7 (35) | 12 (60) | <0.205 |
| Single | 13 (65) | 8 (40) | |
| Education, | |||
| High school | 1 (5) | 4 (20) | <0.421 |
| College | 14 (70) | 12 (60) | |
| Graduates or above | 5 (25) | 4 (20) | |
| Past drug/alcohol use, | |||
| Recreational | 9 (45) | 5 (25) | <0.076 |
| Misuse | 1 (5) | 2 (10) | |
| Dependence | 1 (5) | 7 (35) | |
| None | 9 (45) | 6 (30) | |
| Employment, | |||
| Unemployed | 8 (40) | 13 (65) | <0.205 |
| Employed | 12 (60) | 7 (35) | |
| Diagnoses, | |||
| Depression | 7 (35) | 5 (25) | <0.445 |
| Generalised anxiety disorder | 2 (10) | 2 (10) | |
| Post-traumatic stress disorder | 4 (20) | 1 (5) | |
| Mixed anxiety and depression | 3 (15) | 7 (35) | |
| Personality disorder | 0 (0) | 1 (5) | |
| Anxiety disorder | 2 (10) | 1 (5) | |
| Adjustment disorder | 2 (10) | 1 (5) | |
| More than one diagnoses | 0 (0) | 2 (10) | |
| Family history, | |||
| Yes | 14 (70) | 12 (60) | <0.741 |
| No | 6 (30) | 8 (40) | |
| Medication, | |||
| Antidepressants | 9 (45) | 7 (35) | <0.644 |
| Anxiolytics | 0 (0) | 1 (5) | |
| Antipsychotics | 0 (0) | 1 (5) | |
| Mood stabilisers | 6 (30) | 8 (40) | |
| Multiple medication | 5 (25) | 3 (15) | |
| HADS Anxiety, mean (s.d.) | 11.25 (1.74) | 10.75 (3.04) | <0.512 |
| HADS Depression, mean (s.d.) | 10.10 (1.74) | 9.25 (2.22) | <0.289 |
| HADS Total, mean (s.d.) | 21.35 (2.41) | 20 (4.5) | <0.414 |
| CORE, mean (s.d.) | 74.25 (19.81) | 69.45 (21.60) | <0.355 |
| WHO-DAS, mean (s.d.) | 23.05 (6.40) | 21.45 (5.28) | <0.341 |
TAU, treatment as usual; HADS, Hospital Anxiety and Depression Scale; CORE, Clinical Outcomes in Routine Evaluations outcome measure; WHO-DAS, World Health Organization Disability Assessment Schedule 2.0.
P-values were calculated using non-parametric Mann–Whitney U-test for continuous variables (age and clinical matrices) and Fisher's exact test for the rest of variables that were categorical.
Family history of any psychiatric diagnosis.
Differences between the treatment and control groups, both uncontrolled and controlled for baseline differences
| Post-trial unadjusted group means (s.d.) post trial | Mean differences adjusted for baseline outcome | ||||||
|---|---|---|---|---|---|---|---|
| Intervention ( | TAU ( | Mean difference between groups post trial (95% CI) | Partial η2 | (numDF, denDF) | Cohen's | ||
| HADS Anxiety | 5.3 (1.7) | 8.4 (2.6) | −3.6 (−4.7 to −2.5) | 0.60 | (1.30) 45.2 | 1.65 | <0.001 |
| HADS Depression | 3.9 (2.2) | 7.0 (2.1) | −3.8 (−5.0 to −2.6) | 0.57 | (1.30) 40.3 | 1.77 | <0.001 |
| HADS Total | 9.2 (3.7) | 15.4 (4.2) | −7.5 (−9.7 to −5.2) | 0.51 | (1.30) 46.4 | 1.90 | <0.001 |
| CORE | 31.1 (20.7) | 57.3 (18.9) | −25.3 (−39.8 to −10.7) | 0.29 | (1.30) 12.5 | 1.27 | 0.001 |
| WHO-DAS 2.0 | 11.8 (8.7) | 19.7 (11.3) | −7.9 (−15.3 to −0.5) | 0.14 | (1.30) 4.8 | 0.80 | 0.036 |
TAU, treatment as usual; numDF, numerators for degrees of freedom; denDF, denominators for degrees of freedom; HADS, Hospital Anxiety and Depression Scale; CORE, Clinical Outcomes in Routine Evaluations outcome measure; WHO-DAS, World Health Organization Disability Assessment Schedule 2.0.
Cohen's d was calculated by dividing the adjusted difference at the end of the trial by the pooled SD at baseline.
P-values calculated using ANCOVA, controlling for baseline value of the outcome.
Sensitivity analysis
| Post-trial unadjusted group mean (s.d.) | Mean differences adjusted for baseline outcome | ||||||
|---|---|---|---|---|---|---|---|
| Intervention ( | TAU ( | Mean difference between groups at post trial (95% CI) | Partial η2 | (numDF, denDF) | Cohen's | ||
| HADS Anxiety | 6.1 (2.6) | 8.9 (2.6) | −2.9 (−4.5 to −1.40) | 0.29 | (1.37) 14.8 | 1.12 | <0.001 |
| HADS Depression | 4.8 (2.9) | 7.4 (2.0) | −3.1 (−4.6 to −1.6) | 0.32 | (1.37) 17.9 | 1.24 | <0.001 |
| HADS Total | 11.0 (5.5) | 16.3 (4.1) | −6.0 (−9.0 to −2.0) | 0.30 | (1.37) 16.5 | 1.24 | <0.001 |
| CORE | 37.5 (24.7) | 59.6 (17.4) | −21.6 (−35.5 to −7.7) | 0.21 | (1.37) 9.9 | 1.01 | 0.003 |
| WHO-DAS 2.0 | 13.5 (8.9) | 19.9 (10.0) | −6.6 (−12.8 to −0.4) | 0.11 | (1.37) 4.6 | 0.70 | 0.038 |
TAU, treatment as usual; numDF, numerators for degrees of freedom; denDF, denominators for degrees of freedom; HADS, Hospital Anxiety and Depression Scale; CORE, Clinical Outcomes in Routine Evaluations outcome measure; WHO-DAS, World Health Organization Disability Assessment Schedule 2.0.
Last-observation carried-forward was used to impute missing values for the seven patients who dropped out. Differences between the treatment and control groups, both uncontrolled and controlled for baseline differences. Analyses were carried out using an ANCOVA.
Cohen's d was calculated by dividing the adjusted difference at end of trial by the pooled standard deviation at baseline.
P-values calculated using ANCOVA, controlling for baseline value of the outcome.